Leqembi® Pen subcutaneous formulation approved in Japan
Go back to Leqembi® Pen subcutaneous formulation approved in Japan| BARNES GROUP, Inc. (NYSE: B) | Delayed: 43.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.88 | 52 Week High | $44.27 | |||
| Open | $43.88 | 52 Week Low | $30.07 | |||
| Day High | $43.88 | P/E | 33.50 | |||
| Day Low | $43.88 | EPS | $1.31 | |||
| Volume | 29,874 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 8.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.46 | 52 Week High | $8.73 | |||
| Open | $8.46 | 52 Week Low | $2.86 | |||
| Day High | $8.46 | P/E | N/A | |||
| Day Low | $8.46 | EPS | $-3.82 | |||
| Volume | 154 | |||||
